BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16708116)

  • 21. Rapid in vivo induction of leukocyte tissue factor mRNA and protein synthesis following low dose endotoxin administration to rabbits.
    Brutzki TC; Kulczycky MJ; Bardossy L; Clarke BJ; Blajchman MA
    Hematol J; 2001; 2(3):188-95. PubMed ID: 11920244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The key roles of complement and tissue factor in Escherichia coli-induced coagulation in human whole blood.
    Landsem A; Fure H; Christiansen D; Nielsen EW; Østerud B; Mollnes TE; Brekke OL
    Clin Exp Immunol; 2015 Oct; 182(1):81-9. PubMed ID: 26241501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IMPACT OF OBESITY ON ENDOTOXIN-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION.
    Duburcq T; Tournoys A; Gnemmi V; Hubert T; Gmyr V; Pattou F; Jourdain M
    Shock; 2015 Oct; 44(4):341-7. PubMed ID: 26125085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparin blunts endotoxin-induced coagulation activation.
    Pernerstorfer T; Hollenstein U; Hansen J; Knechtelsdorfer M; Stohlawetz P; Graninger W; Eichler HG; Speiser W; Jilma B
    Circulation; 1999 Dec 21-28; 100(25):2485-90. PubMed ID: 10604885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC.
    Taylor FB; Wada H; Kinasewitz G
    Crit Care Med; 2000 Sep; 28(9 Suppl):S12-9. PubMed ID: 11007191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. An assay for detection of endotoxin.
    Osterud B; Bjørklid E
    Scand J Haematol; 1982 Aug; 29(2):175-84. PubMed ID: 6813961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombin elaboration in endotoxin-induced intravascular fibrin deposition. A leukocyte dependent process distinct from systemic hypercoagulability.
    Lipinski B; Gurewich V; Hyde E
    Thromb Haemost; 1976 Dec; 36(3):615-22. PubMed ID: 1037155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contact activation of coagulation depends on the maximal lipophilic trigger concentration.
    Stief TW
    Blood Coagul Fibrinolysis; 2012 Jun; 23(4):296-8. PubMed ID: 22473046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement component 5 does not interfere with physiological hemostasis but is essential for Escherichia coli-induced coagulation accompanied by Toll-like receptor 4.
    Landsem A; Fure H; Krey Ludviksen J; Christiansen D; Lau C; Mathisen M; Bergseth G; Nymo S; Lappegård KT; Woodruff TM; Espevik T; Mollnes TE; Brekke OL
    Clin Exp Immunol; 2019 Apr; 196(1):97-110. PubMed ID: 30444525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The fibrinogen functional turbidimetric assay.
    Stief TW
    Clin Appl Thromb Hemost; 2008 Jan; 14(1):84-96. PubMed ID: 18160594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monocyte IL-10 produced in response to lipopolysaccharide modulates thrombin generation by inhibiting tissue factor expression and release of active tissue factor-bound microparticles.
    Poitevin S; Cochery-Nouvellon E; Dupont A; Nguyen P
    Thromb Haemost; 2007 Apr; 97(4):598-607. PubMed ID: 17393023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does endotoxin-activated complement alter myocellular sodium homeostasis during sepsis?
    Wang W; Okamoto K; Jacobs DO
    J Trauma; 2002 May; 52(5):951-61. PubMed ID: 11988665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of intrinsic thrombin generation.
    Stief TW
    Drug Target Insights; 2006; 1():5-10. PubMed ID: 21901053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monocyte cell-surface CD14 expression and soluble CD14 antigen in hemodialysis: evidence for chronic exposure to LPS.
    Nockher WA; Scherberich JE
    Kidney Int; 1995 Nov; 48(5):1469-76. PubMed ID: 8544403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of a novel tissue factor assay in experimental human endotoxemia.
    Marsik C; Quehenberger P; Mackman N; Osterud B; Luther T; Jilma B
    Thromb Res; 2003; 111(4-5):311-5. PubMed ID: 14693180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of conditions for in vitro production of radical oxygen species and expression of tissue factor by canine mononuclear cells and granulocytes for use in high-throughput assays.
    Okano S; Hurley DJ; Bergh MS; Vandenplas ML; Budsberg SC; Moore JN
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):234-42. PubMed ID: 16750570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thromboelastometry as a supplementary tool for evaluation of hemostasis in severe sepsis and septic shock.
    Andersen MG; Hvas CL; Tønnesen E; Hvas AM
    Acta Anaesthesiol Scand; 2014 May; 58(5):525-33. PubMed ID: 24580049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amidolytic assay for procoagulant activity of lymphoid and tumor cells.
    Lando PA; Biazak CE; Edgington TS
    J Immunol Methods; 1986 May; 89(1):131-9. PubMed ID: 3701069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of hemostasis alterations in sepsis.
    Stief TW; Ijagha O; Weiste B; Herzum I; Renz H; Max M
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):179-86. PubMed ID: 17287636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention by glucocorticoids of disseminated intravascular coagulation induced by endotoxin: mechanisms.
    Latour JG; Leger C
    J Lab Clin Med; 1975 Jun; 85(6):934-49. PubMed ID: 1094078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.